is bpc 157 banned by wada 2024 The Truth About Peptide in Sports Medicine: What You Need to Know Check out the full podcast episode on Apple Podcasts, Spotify, or whatever you use to listen to podcasts Big FDA review coming this

Description

Retatrutide is an investigational peptide compound that acts as a triple agonist, targeting three hormone receptors simultaneously: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors

Side effects are rare but may include mild soreness at the injection site

Early days evidence points to BPC quickly becoming a go-to tool in the modern longevity toolkit

With its ability to stimulate the regeneration of nerves, which is often one of the most frustrating and lingering effects of a serious injury, BPC 157 should be considered in the recovery from the most debilitating of injuries